| Typ : |
Tidningen |
| Internet länkar : |
https://doi.org/10.1016/j.ijpharm.2005.08.007 |
|
| Forskargrupper : |
Ann Arbor - Pfizer Global Research & Development |
| Författare : |
Freed A.L, Silbering S.B, Kolodsick K.J, Rossi D, Mahjour M, Kingsmill C.A. |
| Titel : |
The development and stability assessment of extemporaneous pediatric formulations of Accupril. |
| Hänvisningar : |
Int J Pharm 304; 1-2: 135-144. 2005 |
|
| Evidensgrad : |
|
| Fysikalisk stabilitet : |
|
| Kemisk stabilitet : |
|
| Andra metoder : |
|
| Kommentarer : |
|
Förteckning över substanser
 Quinapril
|
 |
 |
 |
 |
200 mg
Accupril® |
| Kphos® |
30 ml |
| Bicitra® |
30 ml |
| Orasweet® |
>> 200 ml |
|
5°C |
 |
| 42 |
 |
|
|
|
|
|
200 mg
Accupril® |
| Kphos® |
30 ml |
| Bicitra® |
30 ml |
| Orasweet SF ® |
>> 200 ml |
|
5°C |
|
| 42 |
|
|
|
|
|
|
200 mg
Accupril® |
| Kphos® |
30 ml |
| Bicitra® |
30 ml |
| Sirap (Sockerlag) |
>> 200 ml |
|
5°C |
|
| 42 |
|
|
|
|
|
